Good decisions start with good data products

Axtria’s DataMAx^TM delivers accurate, consistent, and compliant data products that life sciences teams can trust by mapping complex commercial data to critical business entities. Its domain-specific ontology, robust data quality framework, and embedded BRMS automate validation, transformation, and enrichment to ensure every data set is governed, auditable, and ready for analytics, reporting, or execution.

Axtria’s DataMAx^TM Emerging Pharma is a plug and play, scalable, enterprise-grade SaaS solution for emerging pharma companies to gain instant access to brand-specific insights helping customer-facing teams to manage sales interactions seamlessly.

Axtria DataMAx^TM includes a business rules management system (BRMS) that lets users easily create, edit, and test rules specific to their sales force, brand, or market—without needing technical help. It includes pre-built rules for key commercial processes, a visual simulator to see rule impacts, and a GenAI copilot that speeds up updates, making the entire experience fast, flexible, and user-friendly.

Axtria DataMAx^TM includes data quality functionality that empowers users to configure and monitor a wide spectrum of rules, from foundational checks like attribute-level validations and duplicate detection to advanced cross-schema and business context validations. AI/ML-driven capabilities enhance this further by identifying anomalies, learning from historical patterns, and providing self-service insights to ensure ongoing data integrity and trust.

Axtria DataMAx^TM supports the creation of data products like Analytics Ready Data Sets (ARDs) and Report Ready Data Sets (RRDs), enabling teams to quickly access high-quality, purpose-built data for advanced analytics and reporting.
This accelerates time to insight, enhances cross-functional collaboration, and empowers customers to make data-driven decisions with confidence.